Country: Canada
Language: English
Source: Health Canada
IOFLUPANE (123I)
GE HEALTHCARE CANADA INC
V09AB03
IODINE IOFLUPANE 123 I
74MBq
SOLUTION
IOFLUPANE (123I) 74MBq
INTRAVENOUS
2.5ML/5ML
Schedule C
ROENTGENOGRAPHY
Active ingredient group (AIG) number: 0159810001; AHFS:
APPROVED
2017-12-11
1 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION DATSCAN Ioflupane ( 123 I) 74 MBq/ml solution for injection Diagnostic Radiopharmaceutical GE Healthcare Canada Inc. Date of Approval: 2300 Meadowvale Boulevard December 7, 2017 Mississauga, ON L5N 5P9 Submission Control No.: 201481 2 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ................................................................. 3 SUMMARY PRODUCT INFORMATION .................................................................................... 3 DESCRIPTION ............................................................................................................................... 3 INDICATIONS AND CLINICAL USE ......................................................................................... 4 CONTRAINDICATIONS ............................................................................................................... 4 WARNINGS AND PRECAUTIONS ............................................................................................. 5 ADVERSE REACTIONS ............................................................................................................... 7 DRUG INTERACTIONS ................................................................................................................ 7 DOSAGE AND ADMINISTRATION ............................................................................................ 8 RADIATION DOSIMETRY ......................................................................................................... 10 OVERDOSAGE ............................................................................................................................ 11 ACTION AND CLINICAL PHARMACOLOGY ........................................................................ 12 STORAGE AND STABILITY ..................................................................................................... 13 SPECIAL HANDLING INSTRUCTIONS ........................................................................... Read the complete document